The inactive structure of GLP-1R presented here aligns nicely with a possible role of the GLP-1R ECD as a negative regulator of GLP-1R, although, in contrast to GCGR, we and others have failed to identify mutations in the ECD/ECL interface that increase basal activity of GLP-1R
doi: 10.3389/fendo.2025.1708007 Received 18 September 2025 Revised 30 November 2025 Accepted 01 December 2025 Published 15 December 2025 Volume 16 - 2025 Edited by Dipak Kumar Sahoo, Iowa State University, United States Reviewed by Fernando Hinostroza, Universidad Catlica del Maule, Chile Anil Patani, Sankalchand Patel University, India Updates Copyright 2025 Park
Common Types of Peptides Used for Cardiovascular Support Several types of peptides are currently used or being explored for their ability to support the heart and blood vessels
Although the mouse model can mimic some of the pathological features of PCOS, its differences from human pathophysiology may affect the extrapolation of the results
GLP-1 Agonists for Weight Loss Explore Health and Weight Management Support long-term weight goals with Olympias compounded GLP-1 agonists
Bariatric surgery remains the gold standard for severe obesity (BMI 40 or 35 with complications)
